Literature DB >> 15501782

Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.

Clíona A O'dwyer1, Karen Reddin, Denis Martin, Stephen C Taylor, Andrew R Gorringe, Michael J Hudson, Bernard R Brodeur, Paul R Langford, J Simon Kroll.   

Abstract

Commensal neisseriae share with Neisseria meningitidis (meningococcus) a tendency towards overproduction of the bacterial outer envelope, leading to the formation and release during growth of outer membrane vesicles (OMVs). OMVs from both meningococci and commensal neisseriae have shown promise as vaccines to protect against meningococcal disease. We report here the successful expression at high levels of heterologous proteins in commensal neisseriae and the display, in its native conformation, of one meningococcal outer membrane protein vaccine candidate, NspA, in OMVs prepared from such a recombinant Neisseria flavescens strain. These NspA-containing OMVs conferred protection against otherwise lethal intraperitoneal challenge of mice with N. meningitidis serogroup B, and sera raised against them mediated opsonophagocytosis of meningococcal strains expressing this antigen. This development promises to facilitate the design of novel vaccines containing membrane protein antigens that are otherwise difficult to present in native conformation that provide cross-protective efficacy in the prevention of meningococcal disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15501782      PMCID: PMC523026          DOI: 10.1128/IAI.72.11.6511-6518.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  23 in total

1.  A promoter probe plasmid based on green fluorescent protein : a strategy for studying meningococcal gene expression.

Authors:  S A Webb; P R Langford; J S Kroll
Journal:  Methods Mol Med       Date:  2001

2.  Highly conserved Neisseria meningitidis surface protein confers protection against experimental infection.

Authors:  D Martin; N Cadieux; J Hamel; B R Brodeur
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

3.  Immunologic response of man to group B meningococcal polysaccharide vaccines.

Authors:  F A Wyle; M S Artenstein; B L Brandt; E C Tramont; D L Kasper; P L Altieri; S L Berman; J P Lowenthal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

Review 4.  Vaccine prevention of meningococcal disease, coming soon?

Authors:  S L Morley; A J Pollard
Journal:  Vaccine       Date:  2001-12-12       Impact factor: 3.641

5.  Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team.

Authors:  M L Tondella; T Popovic; N E Rosenstein; D B Lake; G M Carlone; L W Mayer; B A Perkins
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine.

Authors:  E Rosenqvist; E A Høiby; E Wedege; K Bryn; J Kolberg; A Klem; E Rønnild; G Bjune; H Nøkleby
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

7.  Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.

Authors:  R Gold; I Goldschneider; M L Lepow; T F Draper; M Randolph
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

8.  Meningococcal infections in England and Wales: 1994.

Authors:  D M Jones; E B Kaczmarski
Journal:  Commun Dis Rep CDR Rev       Date:  1995-08-18

9.  Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba.

Authors:  G V Sierra; H C Campa; N M Varcacel; I L Garcia; P L Izquierdo; P F Sotolongo; G V Casanueva; C O Rico; C R Rodriguez; M H Terry
Journal:  NIPH Ann       Date:  1991-12

10.  Neisseria lactamica protects against experimental meningococcal infection.

Authors:  Kerry J Oliver; Karen M Reddin; Philippa Bracegirdle; Michael J Hudson; Ray Borrow; Ian M Feavers; Andrew Robinson; Keith Cartwright; Andrew R Gorringe
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

View more
  14 in total

1.  Inactivation of NMB0419, Encoding a Sel1-Like Repeat (SLR) Protein, in Neisseria meningitidis Is Associated with Differential Expression of Genes Belonging to the Fur Regulon and Reduced Intraepithelial Replication.

Authors:  Ming-Shi Li; Paul R Langford; J Simon Kroll
Journal:  Infect Immun       Date:  2017-04-21       Impact factor: 3.441

2.  Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies.

Authors:  Linxiao Chen; Jenny L Valentine; Chung-Jr Huang; Christine E Endicott; Tyler D Moeller; Jed A Rasmussen; Joshua R Fletcher; Joseph M Boll; Joseph A Rosenthal; Justyna Dobruchowska; Zhirui Wang; Christian Heiss; Parastoo Azadi; David Putnam; M Stephen Trent; Bradley D Jones; Matthew P DeLisa
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

Review 3.  Review of meningococcal group B vaccines.

Authors:  Dan M Granoff
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

4.  New plasmid tools for genetic analysis of Actinobacillus pleuropneumoniae and other pasteurellaceae.

Authors:  Janine T Bossé; Andrew L Durham; Andrew N Rycroft; J Simon Kroll; Paul R Langford
Journal:  Appl Environ Microbiol       Date:  2009-08-07       Impact factor: 4.792

5.  Immunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.

Authors:  Maneesha Muralinath; Meta J Kuehn; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-11-29       Impact factor: 3.441

6.  Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870.

Authors:  Victor C Hou; Oliver Koeberling; Jo Anne Welsch; Dan M Granoff
Journal:  J Infect Dis       Date:  2005-07-15       Impact factor: 5.226

Review 7.  Microbial biosynthesis of designer outer membrane vesicles.

Authors:  Jenny L Baker; Linxiao Chen; Joseph A Rosenthal; David Putnam; Matthew P DeLisa
Journal:  Curr Opin Biotechnol       Date:  2014-03-22       Impact factor: 9.740

8.  Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Authors:  Stefan Schild; Eric J Nelson; Anne L Bishop; Andrew Camilli
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

9.  Population structure in the Neisseria, and the biological significance of fuzzy species.

Authors:  Jukka Corander; Thomas R Connor; Clíona A O'Dwyer; J Simon Kroll; William P Hanage
Journal:  J R Soc Interface       Date:  2011-11-09       Impact factor: 4.118

10.  Genome wide expression profiling reveals suppression of host defence responses during colonisation by Neisseria meningitides but not N. lactamica.

Authors:  Hazel En En Wong; Ming-Shi Li; J Simon Kroll; Martin L Hibberd; Paul R Langford
Journal:  PLoS One       Date:  2011-10-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.